GLP1R and Alzheimer disease: Better cognition associated with higher plasma GLP-1 levels (MMSE).Reduced Aβ burden and improved learning/memory in multiple AD models.Preserved cortical/temporal lobe volume with modest cognitive benefit in a phase II trial.